Login / Signup

Surveillance of pediatric parapneumonic effusion/empyema in New Zealand.

Katherine Rix-TrottCatherine Ann ByrnesCatherine A GilchristRichard MatsasTony WallsLesley VossCaroline MahonNigel P DicksonPeter ReedEmma J Best
Published in: Pediatric pulmonology (2021)
New Zealand has a high incidence of pediatric complicated parapneumonic effusion/empyema with significant morbidity. S. aureus was a significant cause of severe empyema in New Zealand, particularly for Māori and Pasifika children. Improvements in vaccine coverage are needed along with strategies to reduce S. aureus disease morbidity.
Keyphrases
  • public health
  • young adults
  • risk factors
  • early onset
  • healthcare
  • affordable care act